Is EVGGF or JNJ a better dividend investment in 2026?

EVGGF currently yields 5.09% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: EVGGF offers higher current income.

What is the dividend yield difference between EVGGF and JNJ?

EVGGF has a forward dividend yield of 5.09% ($3.13/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 2.96 percentage points.

Home › Compare › EVGGF vs JNJ

EVGGF vs JNJ: Dividend Comparison 2026

EVGGF yields 5.09% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EVGGF wins by $6819.30M in total portfolio value

INVESTMENT

TIME HORIZON10 years

EVGGF

● Live price

5.09%

Share price

$61.45

Annual div

$3.13

5Y div CAGR

100%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$6819.33M

Annual income

$6,571,408,783.26

Full EVGGF calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — EVGGF vs JNJ

📍 EVGGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EVGGF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EVGGF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EVGGF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EVGGF

Annual income on $10K today (after 15% tax)

$432.82/yr

After 10yr DRIP, annual income (after tax)

$5,585,697,465.77/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, EVGGF beats the other by $5,585,693,479.78/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EVGGF + JNJ for your $10,000?

EVGGF: 50%JNJ: 50%

100% JNJ50/50100% EVGGF

Portfolio after 10yr

$3409.68M

Annual income

$3,285,706,736.33/yr

Blended yield

96.36%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EVGGF

Analyst Ratings

Hold

Consensus: Hold

Altman Z

6.1

Piotroski

5/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EVGGF buys

JNJ buys

No recent congressional trades found for EVGGF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEVGGFJNJ

Forward yield	5.09% ✓	2.13%
Annual dividend / share	$3.13	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	100% ✓	28%
Portfolio after 10y	$6819.33M ✓	$30.3K
Annual income after 10y	$6,571,408,783.26 ✓	$4,689.40
Total dividends collected	$6801.96M ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Hold	Buy

Year-by-year: EVGGF vs JNJ ($10,000, DRIP)

Year	EVGGF Portfolio	EVGGF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,718	$1,018.40	$10,592	$272.30	+$1.1K → EVGGF
2	$14,769	$2,230.66	$11,289	$357.73	+$3.5K → EVGGF
3	$21,058	$5,255.01	$12,123	$472.89	+$8.9K → EVGGF
4	$36,537	$14,004.88	$13,141	$629.86	+$23.4K → EVGGF
5	$84,514	$45,419.16	$14,408	$846.81	+$70.1K → EVGGF
6	$286,802	$196,371.64	$16,021	$1,151.60	+$270.8K → EVGGF
7	$1,552,476	$1,245,598.67	$18,122	$1,588.22	+$1.53M → EVGGF
8	$14,263,973	$12,602,823.08	$20,930	$2,228.20	+$14.24M → EVGGF
9	$231,698,486	$216,436,035.44	$24,792	$3,191.91	+$231.67M → EVGGF
10	$6,819,326,164	$6,571,408,783.26	$30,274	$4,689.40	+$6819.30M → EVGGF

EVGGF vs JNJ: Complete Analysis 2026

EVGGF — Stock

Evolution AB (publ) develops, produces, markets, and licenses live casino and slots solutions to gaming operators primarily in Europe and the United States. The company runs the game from a casino gaming table, which is streamed in real time and end users make betting decisions on their devices, such as computers, smartphones, tablets, etc. Its portfolio of online live table games primarily includes Live Roulette, Blackjack, Baccarat, Super Sic Bo, Dragon Tiger, Craps, Live Casino Hold'em, Three Card Poker, and Ultimate Texas Hold'em; and operates approximately 1000 tables. The company was formerly known as Evolution Gaming Group AB (publ). Evolution AB (publ) was founded in 2006 and is headquartered in Stockholm, Sweden.

Full EVGGF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this EVGGF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EVGGF vs SCHD EVGGF vs JEPI EVGGF vs O EVGGF vs KO EVGGF vs MAIN EVGGF vs ABBV EVGGF vs MRK EVGGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.